Systolic blood pressure. 35 years or older (range of · People who may be at risk for primary hypertension
1 finding from 1 review
Secondary outcome: all adverse events · People who may be at risk for primary hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Predialysis systolic blood pressure · people with CKD requiring dialysis
1 finding from 1 review
Other side effects · people with CKD requiring dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diastolic blood pressure · people with CKD requiring dialysis
1 finding from 1 review
Cardiovascular mortality · people with CKD requiring dialysis
1 finding from 1 review
Intradialytic hypotension · people with CKD requiring dialysis
Dihydropyridine calcium channel blockers showed no clear difference in intradialytic hypotension compared with placebo/control (low certainty).
1 finding from 1 review
Other side effects · people with CKD requiring dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Predialysis systolic blood pressure · people with CKD requiring dialysis
1 finding from 1 review
Diastolic blood pressure · people with CKD requiring dialysis
1 finding from 1 review
Cardiovascular mortality · people with CKD requiring dialysis
1 finding from 1 review
Intradialytic hypotension · people with CKD requiring dialysis
It is very uncertain whether dihydropyridine calcium channel blockers changes intradialytic hypotension compared with other antihypertensives (very low certainty).
1 finding from 1 review
Variation in the decrease in 24‐hour ambulatory hourly SBP (at 3 to 12 weeks) · adults with primary hypertension
1 finding from 1 review
Variation in the decrease in 24‐hour ambulatory hourly DBP (at 3 to 12 weeks) · adults with primary hypertension
1 finding from 1 review
Height SDS · patients with bone disease in children with chronic kidney disease
1 finding from 1 review
Abnormal bone biopsy Bone histology · patients with bone disease in children with chronic kidney disease
It is very uncertain whether calcium carbonate changes abnormal bone biopsy Bone histology compared with aluminium hydroxide (very low certainty).
1 finding from 1 review
Bone aluminium mg/kg dry weight · patients with bone disease in children with chronic kidney disease
1 finding from 1 review
PTH · patients with bone disease in children with chronic kidney disease
1 finding from 1 review
ALP U/L · patients with bone disease in children with chronic kidney disease
1 finding from 1 review
Hypercalcaemia · patients with bone disease in children with chronic kidney disease
1 finding from 1 review